FindTrial
Sign In

Observing Medication Prescription Safety in the ICU A Three-Step Study at a Cancer Care Centre

Prospective Observational Study on Medication Prescription Errors in the Intensive Care Unit as a Quality Indicator at a Tertiary Cancer Care Centre A Three Phase Approach - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108913
Enrollment
1000
Registered
2026-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

ACTREC Tata Memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted to the ICU and recovery room during the study period

Exclusion criteria

Exclusion criteria: All patients below 18 years of age Patients discharged from ICU or deceased within 12 hours of ICU admission

Design outcomes

Primary

MeasureTime frame
Incidence of Medication Prescription ErrorsTimepoint: Time from patients ICU admission till ICU discharge—

Secondary

MeasureTime frame
Categorization of Medication Prescription Errors based on drug classTimepoint: From patients ICU admission to ICU discharge;Categorization of Medication Prescription Errors based on NCC MERP 2022 severity classTimepoint: From patients ICU admission to ICU discharge—

Countries

India

Contacts

Public ContactDr Amol Kothekar

ACTREC, Tata Memorial Centre

amolkothekar@yahoo.com9769633568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026